1,1,1,3,3,3-hexafluoropropan-2-yl 4-(2-(pyrrolidin-1-yl)benzyl)piperazine-1-carboxylate

ID: ALA4533439

Chembl Id: CHEMBL4533439

PubChem CID: 155547201

Max Phase: Preclinical

Molecular Formula: C19H23F6N3O2

Molecular Weight: 439.40

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(OC(C(F)(F)F)C(F)(F)F)N1CCN(Cc2ccccc2N2CCCC2)CC1

Standard InChI:  InChI=1S/C19H23F6N3O2/c20-18(21,22)16(19(23,24)25)30-17(29)28-11-9-26(10-12-28)13-14-5-1-2-6-15(14)27-7-3-4-8-27/h1-2,5-6,16H,3-4,7-13H2

Standard InChI Key:  XOUXYPLBBIZROA-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4533439

    ---

Associated Targets(Human)

ABHD6 Tchem Monoacylglycerol lipase ABHD6 (331 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MGLL Tchem Monoglyceride lipase (1909 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PLA2G7 Tchem LDL-associated phospholipase A2 (1338 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 439.40Molecular Weight (Monoisotopic): 439.1694AlogP: 4.03#Rotatable Bonds: 4
Polar Surface Area: 36.02Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.63CX LogP: 4.09CX LogD: 4.02
Aromatic Rings: 1Heavy Atoms: 30QED Weighted: 0.66Np Likeness Score: -1.11

References

1. Cisar JS, Weber OD, Clapper JR, Blankman JL, Henry CL, Simon GM, Alexander JP, Jones TK, Ezekowitz RAB, O'Neill GP, Grice CA..  (2018)  Identification of ABX-1431, a Selective Inhibitor of Monoacylglycerol Lipase and Clinical Candidate for Treatment of Neurological Disorders.,  61  (20): [PMID:30067909] [10.1021/acs.jmedchem.8b00951]

Source